Dr. Daniela Annenelie Bota, MD

Dr. Bota practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Bota's NPI, 1942499884, was assigned on October 16, 2007. Dr. Bota graduated from Carol Davila University of Medicine and Pharmacy in 1997. Dr. Bota holds California license A101786.

Dr. Bota's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Bota's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bota practices. Vendor and product names are available with a free account.

Neurology is Dr. Bota's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Bota is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Bota's licenses on file in 2 states: California and North Carolina.

Dmand AI lists muscle weakness among the conditions Dr. Bota treats.

CMS data shows 24 Medicare services from Dr. Bota across 1 procedure code in 2021, all of them office visits. Medicare paid $3,682 for them. Every service was in an office.

Across all payers, Dmand AI patient panel data puts Dr. Bota's median patient age at 58, with 61% women.

In 2018, Dr. Bota wrote 15 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $651 in total drug cost. In 2017, CMS named 68 claims across 3 drugs.

Dr. Bota accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 75 papers to Dr. Bota, published from 2009 to 2025. 2016 was the busiest year, with 6. The most frequent topics are Brain Neoplasms, Antineoplastic Agents and Glioblastoma. Dr. Bota has published most often in J Neurooncol. Dr. Bota's most frequent co-authors are Frank Pk Hsu, MD, Santosh Kesari, MD, PhD and Mark E. Linskey, MD.

Dmand AI links Dr. Bota to 10 clinical trials, 5 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Glioblastoma, Astrocytoma and Gliosarcoma. University of California, Irvine sponsors the most, 3.

CMS Open Payments shows 114 general payments to Dr. Bota from 7 drug and device companies from 2016 to 2024. Honoraria make up the largest share, 50% of the total. Novocure Inc. paid the most, $60,170.

Dr. Bota graduated from Carol Davila University of Medicine and Pharmacy in 1997. Dr. Bota is a member of ASCO.

Dr. Bota is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.